SCHEMBL21174580

SCHEMBL21174580

Clc1nc2ccc(-c3ccccc3)cc2nc1-c1ccc2c3ccccc3n(-c3ccccc3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
PKM P14618 1/20 0.44
L3MBTL1 Q9Y468 4/20 0.42
ATM Q13315 1/20 0.42
PIK3R1 P27986 1/20 0.40
PIK3CA P42336 1/20 0.40
AVPR1A P37288 1/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
HSP90AA1 P07900 1/20 0.35
DHODH Q02127 2/20 0.35
PDE4B Q07343 1/20 0.35
PDE4D Q08499 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAT2A P31153 1/20 0.34
DHFR P00374 1/20 0.34
TYMS P04818 1/20 0.34
MAPK1 P28482 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21679704 0.92 KDM4E (0.50) KDM4EPKML3MBTL1ATMMAPT
SCHEMBL21174597 0.84 KDM4E (0.50) KDM4EPKML3MBTL1ATMKMT2A
SCHEMBL30421352 0.84 KDM4E (0.50) KDM4EPKML3MBTL1ATMKMT2A
SCHEMBL20886637 0.83 KDM4E (0.46) KDM4EL3MBTL1ATMPIK3R1PIK3CA
SCHEMBL20886638 0.83 KDM4E (0.46) KDM4EL3MBTL1ATMPIK3R1PIK3CA
SCHEMBL21212898 0.82 KDM4E (0.38) KDM4EL3MBTL1ATMPIK3R1PIK3CA
SCHEMBL21213630 0.82 KDM4E (0.38) KDM4EL3MBTL1ATMPIK3R1PIK3CA
SCHEMBL22141844 0.82 KDM4E (0.45) KDM4EL3MBTL1ATMPIK3R1PIK3CA
SCHEMBL17652243 0.81 KDM4E (0.46) KDM4EPKML3MBTL1ATMMAPT
SCHEMBL17234370 0.81 KDM4E (0.41) KDM4EPKML3MBTL1ATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3960733-B1 BENZOCARBAZOLE-BASED COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THEM LG CHEMICAL LTD (KR) 2023-08-09 EP disclosed
US-11581496-B2 Benzocarbazole-based compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-02-14 US disclosed
US-11581496-B2 Benzocarbazole-based compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-02-14 US disclosed
EP-3960733-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-03-02 EP disclosed
EP-3960737-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-03-02 EP disclosed
CN-109890811-B Benzocarbazole-based compound and organic light-emitting device including the same 株式会社LG化学 2021-10-26 CN disclosed
US-20190237680-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-08-01 US disclosed
US-20190237680-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-08-01 US disclosed
EP-3514152-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2019-07-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190237680-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1B1, CYP2C9, CYP3A4 KDM4E 879/4885PKM 2622/4885L3MBTL1 898/4885
US-11581496-B2 Benzocarbazole-based compound and organic light-emitting device comprising same CYP1B1, CYP2C9, CYP3A4 KDM4E 879/4885PKM 2622/4885L3MBTL1 898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.